Theralase Technologies Inc (TLTFF)

[MasterSalix]

Cancer free for a large segment of cancer patients?

I am not going to get into some half-ass oncology debate - but that statement is 100% wrong and the company does not profess this is a cure for the "large segment of cancer patients. "

Currently we are testing for a treatment for a specific type of bladder cancer - and it has shown some PROMISE to MAYBE show some efficacy toward certain kinds of brain cancer tumors. However, there are a large number of cancers (too numerous to list) that this would not be a treatment for. Period.

Again, overselling it. And you don't have to.

What IS great is that there are so few effective treatments for bladder cancer and the certain type of brain cancer that this would be one of the only games in town and HUGE for those particular people.

I would say if everything went 100% perfectly and this was a near 100% effective treatment for the segment they are targeting - you are looking at somewhere in the $1B-$2B area. Just based on the numbers of folks that get this type of cancer, would be good candidates for the treatment, and the current spending on the disease. Again, many multiples - but let's see it for what it is.

It is just that there are natural limitations to the use of this technique on many, many kinds of cancers. So the market is smaller than the "world" of cancer -

If shown to be effective we will get bought up by our eventual partner before long - probably for less than "billions of dollars" - that is just the reality of paying for testing, marketing, and selling the treatment.